MRI Scans to Guide DCIS Breast Cancer Treatment
MRI Radiomic Signatures of DCIS to Optimize Treatment
This project looks at using advanced MRI imaging to help doctors better understand ductal carcinoma in situ (DCIS), the earliest form of breast cancer, so patients can receive the most appropriate treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11105915 on NIH RePORTER |
What this research studies
Many women diagnosed with DCIS, an early form of breast cancer, currently receive treatments like surgery or radiation that might not be necessary for their specific type of cancer. This can lead to unnecessary anxiety and side effects. Our goal is to use detailed MRI scans to find unique patterns, called radiomic features, within the DCIS and the surrounding breast tissue. By identifying these patterns, we hope to better predict which DCIS cases are truly high-risk and which are low-risk. This improved understanding could help doctors tailor treatments more precisely, avoiding overtreatment for many patients.
Who could benefit from this research
Good fit: This research is relevant for women diagnosed with ductal carcinoma in situ (DCIS) who are seeking more personalized treatment options.
Not a fit: Patients whose DCIS has already progressed to invasive breast cancer or those not diagnosed with DCIS would not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could help many women with DCIS avoid unnecessary surgeries, radiation, and other treatments, reducing anxiety and improving their quality of life.
How similar studies have performed: While the use of radiomics in cancer imaging is an emerging field, this specific application to optimize DCIS treatment using MRI features is a novel approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Rahbar, Habibollah — University of Washington
- Study coordinator: Rahbar, Habibollah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.